
Todd Schlesinger, MD, reviews new photodynamic and adjuvant immunotherapy options for keratinocyte carcinoma, plus pipeline therapies and exosome research.

Todd Schlesinger, MD, serves as a board-certified dermatologist, Mohs micrographic surgeon, and clinical investigator based in South Carolina.